| Literature DB >> 36187067 |
Qianyi Liu1, Weishan Ruan1, Zhishang Liu1, Jiefeng Li1, Jiayan Li1.
Abstract
Introduction: Achalasia (AC) is an esophageal motility disorder clinically manifested as dysphagia. Aim: To investigate the effective factors of peroral endoscopic myotomy (POEM) for AC treatment. Material and methods: A total of 182 AC patients treated between August 2019 and September 2020 were enrolled to receive POEM. They were assigned to an effective group (n = 143) and an ineffective group (n = 39). Their clinical data were recorded. The biochemical indices were determined.Entities:
Keywords: achalasia; effective facto; peroral endoscopic myotomy
Year: 2022 PMID: 36187067 PMCID: PMC9511921 DOI: 10.5114/wiitm.2022.114944
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.627
Photo 1POEM procedure. Upper row: Schematic diagram of POEM; lower row: corresponding endoscopic views. 1 – mucosal incision; 2 – separation of submucosa and establishment of the submucosal tunnel; 3–4 – myotomy; 5 – hemostasis
POEM – peroral endoscopic myotomy.
Therapeutic effect of POEM on AC
| Group |
| Eckardt score [point] | Incidence of reflux 1 year after operation (%) | Effective rate after operation (%) | ||
|---|---|---|---|---|---|---|
| Before operation | 1 year after operation | 6 months | 1 year | |||
| Effective | 143 | 5.21 ±1.31 | 2.52 ±0.94 | 21.65 | 81.23% | 73.41% |
| Ineffective | 39 | 5.18 ±1.06 | 3.12 ±0.84 | 46.12 | 76.15% | 69.86% |
| 0.121 | 3.228 | 2.612 | 3.214 | 3.697 | ||
| 0.452 | 0.001 | 0.000 | 0.001 | 0.001 | ||
AC – achalasia, POEM – peroral endoscopic myotomy.
Univariate analysis results of therapeutic effects of POEM on AC
| Clinical feature | Effective group ( | Ineffective group ( | ||
|---|---|---|---|---|
| Gender: | 0.982 | 0.322 | ||
| Male | 79 | 25 | ||
| Female | 64 | 14 | ||
| Age [years] | 42.36 ±11.57 | 43.04 ±10.91 | 0.290 | 0.386 |
| Course of disease [months] | 186.25 ±23.11 | 185.94 ±22.81 | 0.065 | 0.474 |
| Smoking history [n (%)]: | 0.001 | 0.126 | ||
| Yes | 44 | 12 | ||
| No | 99 | 27 | ||
| Drinking history: | 4.964 | 0.026 | ||
| Yes | 49 | 21 | ||
| No | 94 | 18 | ||
| Incision length [cm] | 9.24 ±0.25 | 9.16 ±0.18 | 1.761 | 0.056 |
| Operation time [min] | 69.21 ±10.29 | 68.78 ±11.06 | 0.193 | 0.423 |
| Fasting time [days] | 2.16 ±0.23 | 2.14 ±0.16 | 0.445 | 0.328 |
| Hospital stay [days] | 5.23 ±1.21 | 5.14 ±1.16 | 0.364 | 0.358 |
| Medical expenditure (ten thousand CNY) | 2.13 ±0.17 | 2.06 ±0.15 | 0.094 | 0.119 |
| Eckardt score at 1 year after operation [points] | 2.52 ±0.94 | 3.12 ±0.84 | 3.228 | 0.001 |
| History of diabetes mellitus: | 0.014 | 0.907 | ||
| Yes | 38 | 10 | ||
| No | 105 | 29 | ||
| History of hypertension: | 0.006 | 0.937 | ||
| Yes | 56 | 15 | ||
| No | 87 | 24 | ||
| History of drug allergy: | 0.013 | 0.910 | ||
| Yes | 8 | 2 | ||
| No | 135 | 37 | ||
| RBC [× 1012/l] | 4.09 ±0.35 | 4.14 ±0.62 | 0.476 | 0.317 |
| Hb [g/l] | 147.69 ±12.55 | 121.65 ±20.36 | 7.384 | 0.000 |
| ALT [U/l] | 30.92 ±2.69 | 29.16 ±2.55 | 3.220 | 0.001 |
| TG [mmol/l] | 3.47 ±1.02 | 3.36 ±1.24 | 0.465 | 0.322 |
| LDL [mmol/l] | 2.55 ±0.80 | 2.57 ±0.71 | 0.127 | 0.450 |
| HDL [mmol/l] | 3.69 ±0.55 | 3.58 ±0.77 | 0.788 | 0.216 |
| MPV [fl] | 0.32 ±0.02 | 0.32 ±0.04 | 0.001 | 0.124 |
| WBC [× 109/l] | 9.38 ±2.64 | 12.16 ±1.62 | 6.087 | 0.000 |
| IL-6 [pg/ml] | 229.69 ±40.94 | 289.35 ±39.65 | 7.100 | 0.000 |
| hs-CRP [mg/l]) | 26.69 ±5.33 | 32.85 ±6.94 | 4.774 | 0.000 |
AC – achalasia, ALT – alanine aminotransferase, Hb – hemoglobin, HDL – high-density lipoprotein, hs-CRP – hypersensitive C-reactive protein, IL-6 – interleukin-6, LDL – low-density lipoprotein, MPV – mean platelet volume, POEM – peroral endoscopic myotomy, RBC – red blood cell count, TG – triglyceride, WBC – white blood cell count.
Variable assignment
| Index | Variable assignment |
|---|---|
| History of drinking | No = 0; yes = 1 |
| Eckardt score 1 year after operation | < 2.52 points = 2; 2.52–3.12 points = 1; > 3.12 points = 0 |
| Hb | > 147.69 g/l = 2; 121.65–147.69 g/l = 1; < 121.65 g/l = 0 |
| ALT | > 30.92 U/l = 2; 29.16–30.92 U/l = 1; < 29.16 U/l = 0 |
| WBC | < 9.38 × 109/l = 2; 9.38–12.16 × 109/l = 1; > 12.16 × 109/l = 0 |
| IL-6 | < 229.69 pg/ml = 2; 229.69–289.35 pg/ml = 1; > 289.35 pg/ml = 0 |
| hs-CRP | < 26.69 mg/l = 2; 26.69–32.85 mg/l = 1; > 32.85 mg/l = 0 |
ALT – alanine aminotransferase, Hb – hemoglobin, hs-CRP – hypersensitive C-reactive protein, IL-6 – interleukin-6, WBC – white blood cell count.
Results of multivariate logistic regression analysis
| Factor | SE | β | Wald χ2 | OR | 95% CI |
|---|---|---|---|---|---|
| Drinking history | 0.447 | 0.124 | 13.009 | 1.564 | 1.124–3.241 |
| Eckardt score 1 year after operation | 0.759 | 0.112 | 45.917 | 2.136 | 1.529–3.628 |
| Hb | 0.119 | 0.045 | 6.955 | 1.126 | 1.036–3.225 |
| ALT | 0.449 | 0.129 | 12.124 | 1.567 | 1.264–3.667 |
| WBC | 0.357 | 0.138 | 6.691 | 1.429 | 1.124–3.208 |
| IL-6 | 0.617 | 0.167 | 13.665 | 1.854 | 1.033–3.338 |
| hs-CRP | 0.511 | 0.157 | 10.595 | 1.667 | 1.364–3.675 |
ALT – alanine aminotransferase, Hb – hemoglobin, hs-CRP – hypersensitive C-reactive protein, IL-6 – interleukin-6, WBC – white blood cell count.
Figure 1ROC curve of therapeutic effect of POEM on AC
AC – achalasia, POEM – peroral endoscopic myotomy, ROC – receiver operating characteristic.
ROC curve analysis results of therapeutic effect of POEM on AC
| Index | AUC | Sensitivity (%) | Specificity (%) |
|---|---|---|---|
| History of drinking | 0.871 | 79.1 | 80.9 |
| Eckardt score 1 year after operation | 0.727 | 78.3 | 84.2 |
| Hb | 0.722 | 78.8 | 79.2 |
| ALT | 0.837 | 81.7 | 86.6 |
| WBC | 0.915 | 80.8 | 82.2 |
| IL-6 | 0.864 | 78.9 | 82.4 |
| hs-CRP | 0.855 | 81.3 | 81.8 |
AC – achalasia, ALT – alanine aminotransferase, Hb – hemoglobin, hs-CRP – hypersensitive C-reactive protein, IL-6 – interleukin-6, POEM – peroral endoscopic myotomy, ROC – receiver operating characteristic, WBC – white blood cell count.
Figure 2Nomogram model for predicting therapeutic effect of POEM on AC
AC – achalasia, POEM – peroral endoscopic myotomy.
Figure 3Calibration and discrimination of model predicting therapeutic effects of POEM on AC
AC – achalasia, POEM – peroral endoscopic myotomy.